Skip to content

About Us
Technology
Pipeline
- Overview
- Migaldendranib (MGB)
News
Resources
Careers
Contact

About Us
Technology
Pipeline
- Overview
- Migaldendranib (MGB)
News
Resources
Careers
Contact

Team Category: Board of Directors

Elizabeth Jeffords

Elizabeth Jeffords, President & CEO of Iolyx Therapeutics

Mahesh Karande

Mahesh Karande

Jay Zaveri

Jay Zaveri

George G. Montgomery

George Montgomery

Kannan Rangaramanujam, Ph.D.

Kannan Rangaramanujam

Jeffrey L. Cleland, Ph.D.

Jeff Cleland

Search for:

Recent Posts

Ashvattha Therapeutics to Present Positive Phase 2 Results for Subcutaneous Migaldendranib in Retinal Vascular Disease at ARVO
Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
Ashvattha Therapeutics Accelerates Clinical Development Strategy with Leadership Appointment of Six Leading Retinal Specialists to Clinical Advisory Board
Ashvattha Presents Positive Phase 2 Data for Subcutaneous Migaldendranib at Angiogenesis 2025 Conference
Ashvattha to Present at Upcoming Angiogenesis, Exudation, and Degeneration 2025 and BIO CEO Conferences

Recent Comments

Archives

Categories

In the News
Press Release

Meta

Log in
Entries feed
Comments feed
WordPress.org

Howdy, this is Creativo

We just added a brand new Off Canvas Sidebar. You can change the content you see here by going to Appearance -> Widgets -> Off Canvas Sidebar.

Of course you can also change the design of this sidebar by going to Appearance -> Theme Options -> Off Canvas Sidebar.

Change everything from: background color, font color, font size, sidebar headings and more.

© Copyright 2025 Ashvattha Therapeutics.

Privacy Policy

© 2025 Ashvattha Therapeutics • Built with GeneratePress